Science News
Latest science news and updates
Total: 154
Turning Back the Biological Clock: Cellular Reprogramming Braces for Human Trials
Partial cellular reprogramming, a biotechnology aimed at reversing the aging process by resetting cellular markers, is set to begin its first human clinical trials this year following promising results in animal models.
Life’s Blueprints in the Red Dust: Curiosity Unearths New Molecular Clues on Mars
NASA's Curiosity rover has detected nitrogen molecules similar to DNA precursors and complex sulfur compounds in Gale Crater, offering the most detailed evidence yet of Mars' ancient organic complexity.
Stem Cell Breakthrough: Solving the Stability Puzzle in Type 1 Diabetes Treatment
Researchers at the Karolinska Institute have developed a technology to stabilize the production of insulin-secreting cells from human stem cells. This breakthrough addresses a major technical bottleneck in regenerative medicine, paving the way for more reliable and scalable stem cell treatments for Type 1 diabetes.
Atomic Precision: Nieng Yan’s Breakthrough Marks a New Era for China’s Biotech Ambitions
Nieng Yan’s team has achieved a 1.8Å resolution mapping of complex glycans, utilizing AI-driven modeling and advanced cryo-EM. This breakthrough, published in Science, underscores Shenzhen's emerging status as a global epicenter for fundamental biological research and the effective integration of AI in structural biology.
A Breath of Prevention: Graphene Sensors Promise Rapid Screenings for Chronic Illness
Russian researchers have developed a graphene-polymer sensor capable of detecting chronic diseases like diabetes and heart failure through breath analysis. This non-invasive technology offers a rapid, highly sensitive alternative to traditional diagnostic methods, potentially revolutionizing early-stage medical screening.
Chasing the Holy Grail: HEC Pharm’s Triple Threat at AACR 2026 Signals China’s Oncology Pivot
HEC Pharm presented three innovative oncology candidates at the 2026 AACR meeting, showcasing breakthroughs in Pan-RAS molecular glues, bispecific antibodies, and oral PD-L1 inhibitors. This move highlights the company's strategic pivot toward high-complexity R&D and its ambition to compete in the global precision medicine market.
The Nuclear Designer’s Private Covenant: Humanizing the Architect of China’s Submarine Fleet
A newly public 1999 'contract' between the late nuclear scientist Peng Shilu and his granddaughter highlights the personal side of the man who led China's nuclear submarine development. The document humanizes a figure who spent decades in state-mandated secrecy, bridging his revolutionary background with a relatable family life.
Regulatory Renaissance: How New Policy Orders are Unlocking China’s Stem Cell Ambitions
China is implementing a landmark regulatory overhaul to streamline the transition of stem cell research from hospital labs to clinical practice. Centered in Shanghai's Zhangjiang hub, this new policy framework aims to leverage real-world clinical data to establish global leadership in regenerative medicine while enforcing strict ethical and safety standards.
Salubris Biotherapeutics Unveils Promising Clinical Data for Novel ADC, Signaling China’s Global Precision Oncology Push
Salubris Biotherapeutics has reported positive Phase 1/2 clinical data for its 5T4-targeting ADC, JK06, at the AACR 2026 conference. The drug shows promising safety and efficacy in treating advanced lung and breast cancers, marking a key advancement in the company's international clinical pipeline.
China’s Shenzhou-21 Achieves Record-Breaking Spacewalk as Mission Duration Is Extended
The Shenzhou-21 crew completed their third spacewalk, setting a new individual record for astronaut Zhang Lu and marking the successful installation of debris protection on the Tiangong station. To further test long-term residency technologies and logistics, the mission duration has been extended by one month.
The Great Leap for Regenerative Medicine: Japan’s Regulatory Gamble Sparks a Global iPSC Race
The global iPSC therapy market has entered a critical clinical phase following Japan's landmark 2026 conditional approvals for heart failure and Parkinson's treatments. While breakthroughs in China and the US demonstrate the curative potential for chronic diseases, the industry must now solve the dual challenges of high manufacturing costs and regulatory safety monitoring.
Submerged Strategy: China Unveils First Comprehensive Geochemical Map of Eastern Seabed
China has released its first comprehensive geochemical map of the eastern seabed, the result of a 20-year survey involving 20,000 data points and machine learning. The map charts the distribution of strategic minerals like rare earth elements, providing a critical data foundation for future resource extraction and maritime spatial planning.